Chandrasekar Gopalakrishnan
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 15, 2021
Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee Replacement.Chandrasekar Gopalakrishnan, Rishi J Desai, Jessica M Franklin
|Dec 24, 2019
Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation.Krista F Huybrechts, Chandrasekar Gopalakrishnan, Dorothee B Bartels
|Jun 27, 2019
Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride.Elisabetta Patorno, Sebastian Schneeweiss, Chandrasekar Gopalakrishnan
|Apr 04, 2019
Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care.Elisabetta Patorno, Chandrasekar Gopalakrishnan, Kimberly G Brodovicz
|Mar 01, 2019
Preferential prescribing and utilization trends of diabetes medications among patients with renal impairment: Emerging role of linagliptin and other dipeptidyl peptidase 4 inhibitors.Elisabetta Patorno, Chandrasekar Gopalakrishnan, Dorothee B Bartels
|Oct 21, 2018
Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records.Krista F Huybrechts, Chandrasekar Gopalakrishnan, Jessica M Franklin
Pageof 2
